Needham Downgrades Shockwave Medical to Hold
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Mike Matson downgraded Shockwave Medical (NASDAQ:SWAV) from Buy to Hold, indicating a change in the investment firm's outlook on the company.

April 05, 2024 | 1:49 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Shockwave Medical was downgraded by Needham from Buy to Hold, reflecting a more cautious view on the company's stock by the analyst.
Analyst downgrades typically lead to a negative perception among investors, potentially causing a short-term decline in the stock price. The downgrade from Buy to Hold suggests that the analyst sees limited upside potential or increased risks that could hamper the stock's performance.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100